Total Costs & Expenses

$2.64B

TTM · Period ending: Jun 30, 2026 · USD

WST Total Costs & Expenses

Latest reported$2.64Bperiod endingJun 30, 2026

WST TTM Total Costs & Expenses (-$204.80M → $2.64B)

TTM Total Costs & Expenses

High-resolution chart · PNG

WST total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

West Pharmaceutical Services Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period ending	Total Costs & Expenses (USD)
Jun 30, 2026	2,639,500,000
Mar 31, 2026	2,554,300,000
Dec 31, 2025	2,456,300,000
Sep 30, 2025	2,386,300,000
Jun 30, 2025	2,334,800,000
Mar 31, 2025	2,298,000,000
Dec 31, 2024	2,296,500,000
Sep 30, 2024	2,280,100,000
Jun 30, 2024	2,257,400,000
Mar 31, 2024	2,253,100,000
Dec 31, 2023	2,233,200,000
Sep 30, 2023	2,218,300,000
Jun 30, 2023	2,160,700,000
Mar 31, 2023	2,141,500,000
Dec 31, 2022	2,126,000,000
Sep 30, 2022	2,127,500,000
Jun 30, 2022	2,151,800,000
Mar 31, 2022	2,118,300,000
Dec 31, 2021	2,076,100,000
Sep 30, 2021	1,986,000,000
Jun 30, 2021	1,904,500,000
Mar 31, 2021	1,809,000,000
Dec 31, 2020	1,725,100,000
Sep 30, 2020	1,663,800,000
Jun 30, 2020	1,604,800,000
Mar 31, 2020	1,577,900,000
Dec 31, 2019	1,546,300,000
Sep 30, 2019	1,484,900,000
Jun 30, 2019	1,479,900,000
Mar 31, 2019	1,481,300,000
Dec 31, 2018	1,473,200,000
Sep 30, 2018	1,493,800,000
Jun 30, 2018	1,469,600,000
Mar 31, 2018	1,420,200,000
Dec 31, 2017	1,379,300,000
Sep 30, 2017	1,351,600,000
Jun 30, 2017	1,321,700,000
Mar 31, 2017	1,303,900,000
Dec 31, 2016	1,309,800,000
Sep 30, 2016	1,296,100,000
Jun 30, 2016	1,320,600,000
Mar 31, 2016	1,315,900,000
Dec 31, 2015	1,272,700,000
Sep 30, 2015	1,264,900,000
Jun 30, 2015	1,228,500,000
Mar 31, 2015	1,221,700,000
Dec 31, 2014	1,239,600,000
Sep 30, 2014	1,238,700,000
Jun 30, 2014	1,229,100,000
Mar 31, 2014	1,217,400,000
Dec 31, 2013	1,206,500,000
Sep 30, 2013	1,191,900,000
Jun 30, 2013	1,167,400,000
Mar 31, 2013	1,153,800,000
Dec 31, 2012	1,131,900,000
Sep 30, 2012	1,109,100,000
Jun 30, 2012	1,097,800,000
Mar 31, 2012	1,088,100,000
Dec 31, 2011	1,080,700,000
Sep 30, 2011	1,068,500,000
Jun 30, 2011	1,048,400,000
Mar 31, 2011	1,019,800,000
Dec 31, 2010	998,400,000
Sep 30, 2010	1,013,900,000
Jun 30, 2010	1,000,800,000
Mar 31, 2010	981,900,000
Dec 31, 2009	957,000,000
Sep 30, 2009	904,500,000
Jun 30, 2009	909,800,000
Mar 31, 2009	914,500,000
Dec 31, 2008	925,800,000
Sep 30, 2008	955,100,000
Aug 5, 2008	946,600,000
Mar 31, 2008	938,700,000
Dec 31, 2007	925,100,000
Sep 30, 2007	887,500,000
Jun 30, 2007	856,400,000
Mar 31, 2007	835,700,000
Dec 31, 2006	812,300,000
Sep 30, 2006	777,900,000
Jun 30, 2006	747,700,000
Mar 31, 2006	692,700,000
Dec 31, 2005	627,500,000
Sep 30, 2005	566,200,000
Jun 30, 2005	526,600,000
Mar 31, 2005	493,800,000
Dec 31, 2004	487,200,000
Sep 30, 2004	468,100,000
Jun 30, 2004	452,400,000
Mar 31, 2004	447,700,000
Dec 31, 2003	436,200,000
Sep 30, 2003	436,400,000
Jun 30, 2003	429,600,000
Mar 31, 2003	411,900,000
Dec 31, 2002	391,600,000
Sep 30, 2002	335,200,000
Jun 30, 2002	330,800,000
Mar 31, 2002	326,700,000
Dec 31, 2001	340,500,000
Sep 30, 2001	400,200,000